share_log

Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $8

Morgan Stanley Maintains Underweight on Bright Health Gr, Lowers Price Target to $8

摩根士丹利维持Bright Health Gr的权重偏低,目标股价下调至8美元
Benzinga ·  2023/08/30 10:12

Morgan Stanley analyst Ricky Goldwasser maintains Bright Health Gr (NYSE:BHG) with a Underweight and lowers the price target from $160 to $8.

摩根士丹利分析师瑞奇·戈德瓦瑟维持Bright Health Gr(纽约证券交易所代码:BHG)的权重偏低,并将目标股价从160美元下调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发